EGFR immunoexpression, RAS immunoexpression and their effects on survival in lung adenocarcinoma cases


Gundogdu A. G. , Onder S. , Firat P., DOĞAN R.

JOURNAL OF THORACIC DISEASE, vol.6, no.6, pp.778-784, 2014 (Journal Indexed in SCI) identifier identifier

  • Publication Type: Article / Article
  • Volume: 6 Issue: 6
  • Publication Date: 2014
  • Doi Number: 10.3978/j.issn.2072-1439.2014.04.35
  • Title of Journal : JOURNAL OF THORACIC DISEASE
  • Page Numbers: pp.778-784

Abstract

Background: The impacts of epidermal growth factor receptor (EGFR) immunoexpression and RAS immunoexpression on the survival and prognosis of lung adenocarcinoma patients are debated in the literature.